Item 2.02 Results of Operations and Financial Condition.
On
Item 7.01. Regulation FD Disclosure.
The disclosure contained in Item 2.02 of this Current Report on Form 8-K is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description Press release issued by the Company on January 09 , 99.1 202 2 . 99.2 Corporate slide deck, dated January 10, 2022. 101 Emergent BioSolutions Inc. Current Report on Form 8-K, dated January 9, 2022 formatted in XBRL (Extensible Business Reporting Language): Cover Page. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
© Edgar Online, source